CONSOLIDATED BALANCE SHEETS (USD $)	Dec. 31, 2011	Dec. 31, 2010
Current assets:
Cash and cash equivalents	$ 4,112,326	$ 1,340,922
Accounts receivable, net	1,891,919	162,376
Inventory, net	712,602	111,554
Prepaid expenses and other current assets	164,664	90,946
Total current assets	6,881,511	1,705,798
Property and equipment, net of accumulated depreciation of $1,814,473 and $1,392,704, respectively	869,411	756,956
Goodwill	4,040,443	857,597
Intangible assets, net of accumulated amortization of $3,468,515 and $2,132,606, respectively	15,090,485	3,929,394
Deposits and other long term assets	214,342	102,500
Total assets	27,096,192	7,352,245
Current liabilities:
Accounts payable and accrued expenses	2,300,638	848,285
Convertible notes, plus accrued interest of $3,432	0	403,432
Deferred rent current	6,620	0
Convertible line of credit with related party, net of unamortized discount of $46,746 plus accrued interest of $42,726	1,295,980	0
Convertible debt related to acquisition, net of unamortized discount of $170,509 plus accrued interest of $49,315	1,128,806	0
Current portion of earn-out liability payable In MiMedx common stock	3,185,223	0
Total current liabilities	7,917,267	1,251,717
Earn-out liability payable in MiMedx common stock, net of current portion	4,225,280	0
Convertible Senior Secured Promissory Notes, net of unamortized discount of $2,263,145 plus accrued interest of $7,732	2,744,587	0
Other liabilities	312,493	0
Total liabilities	15,199,627	1,251,717
Commitments and contingency (Note 15)
Stockholders' equity:
Preferred stock; $.001 par value; 5,000,000 shares authorized and 0 shares issued and outstanding	0	0
Common stock; $.001 par value; 100,000,000 shares authorized; 74,306,895 issued and 74,256,895 outstanding for 2011 and 64,381,910 issued and 64,331,910 outstanding for 2010	74,307	64,382
Additional paid-in capital	73,868,604	57,888,506
Treasury stock (50,000 shares at cost)	(25,000)	(25,000)
Accumulated deficit	(62,021,346)	(51,827,360)
Total stockholders' equity	11,896,565	6,100,528
Total liabilities and stockholders' equity	$ 27,096,192	$ 7,352,245